| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| HULL THOMAS DAVID III | President, CEO, Director | 2700 WEST FRONT STREET, STATESVILLE | /s/ Donald T. Gardner III, Attorney-in-fact | 02 Jan 2026 | 0001657070 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KEQU | Common Stock | Sale | $1,102 | -29 | -0.08% | $38.00 | 35,806 | 30 Dec 2025 | Direct | |
| transaction | KEQU | Common Stock | Sale | $23,688 | -629 | -1.8% | $37.66 | 35,177 | 31 Dec 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.50 to $38.00, inclusive. The reporting person undertakes to provide Kewaunee Scientific Corporation ("Kewaunee"), any security holder of Kewaunee, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |